Lilly's weight loss drug shortage deemed over, but hurdles remain

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Read more at CBS News

Save story

Topics

Related

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
Business - Financial Times - October 30
Amgen says no concerns around weight loss drug’s bone density data after stock falls
Business - CNBC - November 13
Nurse’s death linked to approved weight-loss drug
Top stories - BBC News - November 8
Weight loss drug industry injects wealth into Novo Nordisk home country
Top stories - CBS News - November 3
Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial
Business - MarketWatch - November 4
Counterfeit weight loss drugs sold online as demand for cheaper options grows
Top stories - CBS News - November 8
Counterfeit weight loss drugs feed demand for cheaper options
Top stories - CBS News - November 8
Ozempic, Wegovy popularity leads to rise of fake weight loss drugs
Top stories - CBS News - November 9

More from CBS News

Chris Stapleton wins 4 CMAs but Morgan Wallen named entertainer of the year
Top stories - CBS News - 4 hours ago
"48 Hours" show schedule
Top stories - CBS News - 5 hours ago
Banana duct-taped to wall sells for $6.2 million at NYC art auction
Top stories - CBS News - 6 hours ago
Justice Department calls for breakup of Google and sale of Chrome
Top stories - CBS News - 6 hours ago
American dies in Laos amid reports that several tourists suffered alcohol poisoning
Top stories - CBS News - 6 hours ago